MetaVia Appoints Dr. Sarah Browne as Chief Medical Officer
MetaVia announces Dr. Sarah Browne as Chief Medical Officer to advance its portfolio of cardiometabolic drugs, including Phase 3 candidate DA-1726, stimulating investor interest in the company's pipeline potential.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed